Literature DB >> 25295938

Understanding the role of progranulin in Alzheimer's disease.

Simon D'Alton1, Jada Lewis1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25295938     DOI: 10.1038/nm.3712

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease.

Authors:  Jinghao Sheng; Liling Su; Zhengping Xu; Guangdi Chen
Journal:  Gene       Date:  2014-03-25       Impact factor: 3.688

2.  Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease.

Authors:  Kurt M Lucin; Caitlin E O'Brien; Gregor Bieri; Eva Czirr; Kira I Mosher; Rachelle J Abbey; Diego F Mastroeni; Joseph Rogers; Brian Spencer; Eliezer Masliah; Tony Wyss-Coray
Journal:  Neuron       Date:  2013-09-04       Impact factor: 17.173

Review 3.  Structure, function, and mechanism of progranulin; the brain and beyond.

Authors:  Huishi Toh; Babykumari P Chitramuthu; Hugh P J Bennett; Andrew Bateman
Journal:  J Mol Neurosci       Date:  2011-06-21       Impact factor: 3.444

4.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Authors:  Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

Review 5.  Progranulin in neurodegenerative disease.

Authors:  Terri L Petkau; Blair R Leavitt
Journal:  Trends Neurosci       Date:  2014-05-04       Impact factor: 13.837

Review 6.  Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development.

Authors:  Adam L Boxer; Michael Gold; Edward Huey; Fen-Biao Gao; Edward A Burton; Tiffany Chow; Aimee Kao; Blair R Leavitt; Bruce Lamb; Megan Grether; David Knopman; Nigel J Cairns; Ian R Mackenzie; Laura Mitic; Erik D Roberson; Daniel Van Kammen; Marc Cantillon; Kathleen Zahs; Stephen Salloway; John Morris; Gary Tong; Howard Feldman; Howard Fillit; Susan Dickinson; Zaven Khachaturian; Margaret Sutherland; Robert Farese; Bruce L Miller; Jeffrey Cummings
Journal:  Alzheimers Dement       Date:  2012-10-05       Impact factor: 21.566

7.  Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.

Authors:  Woojin S Kim; Hongyun Li; Kalani Ruberu; Sharon Chan; David A Elliott; Jac Kee Low; David Cheng; Tim Karl; Brett Garner
Journal:  J Neurosci       Date:  2013-03-06       Impact factor: 6.167

8.  Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.

Authors:  Sandra Pereson; Hans Wils; Gernot Kleinberger; Eileen McGowan; Mado Vandewoestyne; Bianca Van Broeck; Geert Joris; Ivy Cuijt; Dieter Deforce; Michael Hutton; Christine Van Broeckhoven; Samir Kumar-Singh
Journal:  J Pathol       Date:  2009-10       Impact factor: 7.996

9.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.

Authors:  Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

10.  Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.

Authors:  S Sakura Minami; Sang-Won Min; Grietje Krabbe; Chao Wang; Yungui Zhou; Rustam Asgarov; Yaqiao Li; Lauren H Martens; Lisa P Elia; Michael E Ward; Lennart Mucke; Robert V Farese; Li Gan
Journal:  Nat Med       Date:  2014-09-28       Impact factor: 53.440

View more
  4 in total

1.  Progranulin, a moderator of estrogen/estrogen receptor α binding, regulates bone homeostasis through PERK/p-eIF2 signaling pathway.

Authors:  Yuyou Yang; Naibo Feng; Li Liang; Rong Jiang; Yiming Pan; Nana Geng; Mengtian Fan; Xiaoli Li; Fengjin Guo
Journal:  J Mol Med (Berl)       Date:  2022-07-15       Impact factor: 5.606

2.  PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis.

Authors:  Hui-Min Xu; Lin Tan; Yu Wan; Meng-Shan Tan; Wei Zhang; Zhan-Jie Zheng; Ling-Li Kong; Zi-Xuan Wang; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-01-28       Impact factor: 5.590

3.  Novel GRN Mutations in Patients with Corticobasal Syndrome.

Authors:  Foad Taghdiri; Christine Sato; Mahdi Ghani; Danielle Moreno; Ekaterina Rogaeva; Maria Carmela Tartaglia
Journal:  Sci Rep       Date:  2016-03-10       Impact factor: 4.379

4.  Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients.

Authors:  Rinko Grewal; Mona Haghighi; Shuai Huang; Amanda G Smith; Chuanhai Cao; Xiaoyang Lin; Daniel C Lee; Nancy Teten; Angela M Hill; Maj-Linda B Selenica
Journal:  Alzheimers Res Ther       Date:  2016-10-18       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.